Teva Octreotide for injectable suspension recall
Teva Octreotide for injectable suspension recalled due to potential drug quality issues
- Published
- 13 Jan 2026
- Agency
- Health Canada
- Country
- Canada
The hazard
Product quality
What to do
If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement product. If you are unsure whether your product is affected, check with your pharmacy. Seek medical attention if you have used this product and are experiencing symptoms of infection, or other unexpected symptoms or side effects. Return affected product(s) to the pharmacy where it was purchased for proper disposal. Consult a health care professional if you have used the affected product and have health concerns. Contact Teva Canada Limited by calling toll-free at 1-800-268-4127, option 3, or by email at [email protected], if you have questions about this recall. Report any health product-related side effects or complaints to Health Canada.
- Stop using the product until you have checked whether yours is affected.
- Compare model numbers, batch codes and dates on the label with the official notice.
- Contact the company in the notice for your refund, repair or replacement. Do not sell or give it away.
Source: Health Canada, published 13 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.